THERAPEUTIC IMMUNOPHARMACOLOGY

被引:5
作者
HADDEN, JW
机构
关键词
D O I
10.1016/0952-7915(89)90197-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:258 / 263
页数:6
相关论文
共 30 条
[1]   IMMUNOMODULATORY PROPERTIES OF CIMETIDINE IN ARC PATIENTS [J].
BROCKMEYER, NH ;
KREUZFELDER, E ;
MERTINS, L ;
CHALABI, N ;
KIRCH, W ;
SCHEIERMANN, N ;
GOOS, M ;
OHNHAUS, EE .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 48 (01) :50-60
[2]  
CRUSE JM, 1989, EOS-RIV IMMUNOL, V9, P41
[3]  
DESIMONE C, 1989, EOS J IMMUNOL IMMUNO, V9, P184
[4]   TUMOR NECROSIS FACTOR - STILL A PROMISING AGENT [J].
FREI, E ;
SPRIGGS, D .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (03) :291-294
[5]   EFFECT OF GRANULOCYTE COLONY-STIMULATING FACTOR ON NEUTROPENIA AND ASSOCIATED MORBIDITY DUE TO CHEMOTHERAPY FOR TRANSITIONAL-CELL CARCINOMA OF THE UROTHELIUM [J].
GABRILOVE, JL ;
JAKUBOWSKI, A ;
SCHER, H ;
STERNBERG, C ;
WONG, G ;
GROUS, J ;
YAGODA, A ;
FAIN, K ;
MOORE, MAS ;
CLARKSON, B ;
OETTGEN, HF ;
ALTON, K ;
WELTE, K ;
SOUZA, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (22) :1414-1422
[6]  
GIBBONS JJ, 1989, J IMMUNOL, V142, P1867
[7]   THE ROLE OF INTERFERON IN CANCER-THERAPY - A CURRENT PERSPECTIVE [J].
GOLDSTEIN, D ;
LASZLO, J .
CA-A CANCER JOURNAL FOR CLINICIANS, 1988, 38 (05) :258-275
[8]  
HADDEN JW, 1988, CANCER DETECT PREV, V12, P537
[9]  
HADDEN JW, 1989, ADV IMMUNOPHARMACOL, V4, P19
[10]  
HOM JT, 1988, J IMMUNOL, V141, P834